I am writing to strongly recommend the promotion of Nicolas Sluis-Cremer, Ph.D., to the rank of Professor of Medicine with tenure in the Investigator-Educator track. Dr. Sluis-Cremer’s accom-plishments as a biochemist, translational scientist, and educator are exceptional and most deserving of promotion to this rank. Dr. Sluis-Cremer’s academic training and record of research, teaching, mentoring and service are thoroughly reviewed below. Training and Faculty Record Dr. Sluis-Cremer received his Ph.D. in Biophysics and Biochemistry in 1997 from the University of Witwatersrand, Johannesburg, South Africa. From 1998 to 2001, he completed a Postdoctoral Fellowship with Michael A. Parniak, Ph.D., at the McGill University AIDS Center, Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Canada. In 2001, Dr. Sluis-Cremer was appointed Research Assistant Professor (non-tenure track) in the Department of Medicine, Division of Infectious Diseases, University of Pittsburgh, and was promoted to the rank of Assistant Professor of Medicine (tenure track) in 2004. He was promoted to the rank of Associate Professor of Medicine with tenure in 2010. …show more content…
Sluis-Cremer was awarded a secondary faculty appointment as Associate Professor in the Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine in 2004. He holds a secondary faculty appointment as Associate Professor in the Department of Infectious Diseases and Microbiology, University of Pittsburgh Graduate School of Public Health since 2008. Dr. Sluis-Cremer serves as a Faculty Member of the Graduate Program in Molecular Virology and Microbiology, Interdisciplinary Biomedical Graduate Program, University of Pittsburgh School of
Prior to medical school, Doctor Clifford Dacso studied the philosophy of science4 and although this field does not directly correlate with his work as a doctor today, it gave him the foundation he needed to become the established and awarded scientist he is today. Dr. Dacso has an extensive list of education, as he has returned to study at many universities post-doc. Besides graduating as a Doctor of Medicine (M.D.), he is also a Master of Arts (M.A.) and a Master of Public Health (M.P.H.). Furthermore, he has also received his Master of Business Administration (M.B.A.) from Pepperdine University.4 Dr. Clifford Dacso is currently a professor of molecular and cell biology at the Baylor School of Medicine.1 In his research, Dr. Dacso aspires
Rufus Cole, the director of the Hospital of the Rockefeller Institute for Medical Research, became interested in Avery’s work, specifically on tuberculosis.. Consequently, Cole offered a job which Avery accepted in 1913. Avery then worked 35 years on one specific species of pneumonia-creating bacteria called Pneumococcus. His partners were elite class scientists including as Alphonse R. Dochez, René Dubos, Harriett Ephrussi-Taylor, Michael Heidelberger, Rebecca Craighill Lancefield, Maclyn McCarty, and Colin MacLeod.
The vaginal tract is the most susceptible site when compared with the other mucosal sites such as oral and anal sites (16, 17, 34, 36). To obtain the robust and unbiased results, we will include up to six samples (3-4 samples are commonly used for this kind of study) of each group for RNA sequencing. To minimize the variables in the study, we plan to use the inbred mouse strain (NU/J-Foxn1nu/J). To minimize the variation in age, the siblings of the infected mice without infection will be used as negative controls. In Specific
Zelicoff, is a licensed physician who, at the time of Microbe’s publication, worked at the ARES Corporation, which is a risk management firm. He was personally involved in many of the stories throughout the book, including the SARS outbreak in China and the Smallpox outbreak of 1971. He is also credited with inventing the Rapid Syndrome Validation Program (RSVP). He has also written another book, More Harm Than Good: What Your Doctor May Not Tell You About Common Treatments and Procedures. The second author, Michael Bellomo, holds an MBA and a Juris Doctor in Law.
I’ve spent several summers at the Brickner Microbiology Lab at Northwestern University. I first became involved with the lab the summer after my sophomore year of highschool. I worked as a paid lab technician. I preformed custodial duties and learned how to operate and maintain pieces of lab equipment. During this time I sat in on “Journal Club” paper review sessions and learned about the research projects running at the lab.
Eradicating disease is a public health ideal that has been passed on for years and still stands today with some success stories behind it for humans and animals alike. Disease eradication is defined as the point where the permanent prevalence of infection of a disease is zero worldwide and intervention steps are not needed resulting from intentional work. There are many things to consider when identifying a disease for eradication. Dowdle states that “if the right tools were available, all infectious diseases would be eradicable” but unfortunately this is not the reality (23). There are three basic topics of criteria that have to be met for a infectious disease to be eligible to be considered for eradication efforts: biological, economic, and
Dr. Biscoe transitioned to speaking about the grants he received throughout his years at City College. The American Chemical Society provided him with funding for two years through a petroleum grant. Most of Dr. Biscoe’s ongoing research has been funded by the accumulation of grants through the National Institute of Health, which has been approximated to last for seven years. He also pointed out that several corporations provide him with resources and chemicals that are necessary for his research because they are highly interested in his work. The most inspiring and heart-warming part of this interview is that Dr. Biscoe expressed how phenomenal of a professor and scientist he is by stating that he shares his funding with all of the students that work with him on his research because they deserve it just as much as he
History In 1811, Henri Braconnot (Botany director at the faculty of sciences in Nancy- France) extracted chitin for the first time and named it as ‘fungine’, he noticed that it is not soluble in sulfuric acid. In 1823, Auguste Odier, a French scientist extracted chitin from cuticle of beetles and named it after the Greek word for ‘tunic’, ‘chiton’ and after that ‘chitin’ was used. In 20th century scientists studied more about polymers and their uses, and discovered useful properties. Chitin is environmentally friendly as it is non-toxic and biodegradable and possess a lot of important uses [1,2].
If one were to pick up the research study with no prior knowledge on anything related to the plague, they would have a lot of trouble trying to understand why the study was talking about different microbes instead of just the Y. pestis. The article found in The New York Times does not mention the fact that the study involved the microbe’s ancestor, Y. pseudotueberculousis. While the study was trying to find traces of Y. pestis in raw DNA sequences, the researchers also had to make sure that they were looking for the right microbe. Because there was no mention of this, the reader would think nothing other than the fact that the study must not have been very complicated. Zimmer, the author of the article, relays the information in the study with very little detail.
Background Legionella pneumophila acquired its fame through a 1976 American Legion conference for US military veterans, when many attendees came down with pneumonia (pneumophila = “lung-loving”). In nature, they are found in soil or as parasites of fresh-water amoebas. In fact, many of the virulent traits are results from their environment in nature. Sometimes, they team up with other bacteria, algae, and protozoa to form “biofilms”–a lump of trouble protected by complex slime that is hard to remove. In humans, Legionella causes both Legionnaire’s disease (pneumonic) and a milder Pontiac fever (non-pneumonic).
My knowledges of molecular biology, biochemistry and microbiology have grown, but I know there is a lot to learn and, as always, to keep learning is my final goal. This is the moment to challenging myself and pursuit other experiences in an area that involve Biochemistry and Molecular Biology. I want to continue my education at the Graduate Program in Biochemistry and Cell Biology at Rice University. This program is the best option to continue improving my scientific and professional skills. The privileged research conditions of your university, the facilities, the faculty and the outstanding researcher lines make this university the perfect place for a doctoral training.
" Not from the Stars Do I My Judgment Pluck." Emerging Infectious Diseases, vol. 16, no. 8, Aug. 2010, pp. 1335-1336.
On the other hand, according to Institut Pasteur this bacterial infection was first introduced in the 1800’s and in 2002 this infection was reintroduced. In the same manner, that it states in the cosmopolitan age, “Globalization bringing “new” or revived infections”. Furthermore, the time for dying is unclear and it could happen whether is too early or too late according to the value of society. Amy Carter died when she was only 15 years old and the doctors weren’t aware she was dying even though she asked the doctors if she will die, the day she was discharged from the
However, these same bacteria induced considerable increases in CCR5 expression on LP CD4 T cells. CCR5 over expression by HAMB mediated by indirect stimulation of LP CD4 T cells and likely mediated through LPS signaling. These observations highlight that bacteria may utilize diverse mechanisms to contribute to HIV associated pathogenesis. Considering the significance of gut microbiota imbalance, recognizing how microbiome dynamics impacts HIV infection leading to death of intestinal
In 1988 the Nobel Prize for physiology or medicine had been awarded to British researcher James Black (from King’s College London) and two Americans Gertrude Elion and George Hitchings (from Burroughs welcome company in research triangle park, North Carolina) (1). James Black was recognised for creating drugs for treating peptic ulcers and heart disease. The two Americans were honoured in their work in developing drugs for treating gout, malaria, viral infections e.g. herpes and cancer (1). The Approaches the two parties took where totally different, Black solely focussed upon the cell surface receptors to which hormones and various physiological agents must bind to apply fully their effects on their target organs (1).